uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
28.03
+0.46 (1.67%)
Jun 15, 2026, 2:09 PM EDT - Market open
uniQure Market Cap
uniQure has a market cap or net worth of $1.77 billion as of June 15, 2026. Its market cap has increased by 123.15% in one year.
Market Cap
1.77B
Enterprise Value
1.72B
1-Year Change
123.15%
Ranking
Category
Stock Price
$28.03
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.77B, an increase of 997.32%. That is a compound annual growth rate of 29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.77B | 18.60% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.81B |
| Nanobiotix | 1.80B |
| Mesoblast | 1.78B |
| Nurix Therapeutics | 1.75B |
| Agios Pharmaceuticals | 1.75B |
| Nuvation Bio | 1.71B |
| Biohaven | 1.70B |
| Intellia Therapeutics | 1.69B |